James Mahon

8PUBLICATIONS
24CO-AUTHORS
Counselling, wellbeing and community servicesMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Neural engineeringGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 29, 2026
Digital front door technologies to pre-assess people before assessment for NHS Talking Therapies [HTE10055]: early value assessment.

|Sep 10, 2024
Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis.

Nigel Fleeman, Rachel Houten, Sarah Nevitt

|Oct 15, 2023
Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.

Rebecca Bresnahan, Rui Duarte, James Mahon

|Sep 21, 2023
Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.

Marty Chaplin, Rebecca Bresnahan, Nigel Fleeman

|May 17, 2023
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Rebecca Bresnahan, Rachel Houten, Janette Greenhalgh

|Apr 21, 2023
Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Rachel Houten, Nigel Fleeman, James Mahon

Pageof 2

Frequent Collaborators

8 joint publications

Angela Boland

8 joint publications

Sophie Beale

6 joint publications

Rachel Houten

6 joint publications

Nigel Fleeman